Key Takeaways
- Neko Health raises $700 million in Series C funding.
- Company plans to open its first U.S. location in New York.
- Over 100,000 scans completed, with many more on the waitlist.
Neko Health’s New Funding
Neko Health, the health assessment startup co-founded by Spotify’s Daniel Ek, has successfully raised $700 million in its Series C funding round. This investment was led by Lightspeed Venture Partners and O.G. Venture Partners, following a previous $260 million raised in January 2025.
Innovative Health Technology
The company has developed advanced body-scanning technology that works in conjunction with blood tests to evaluate individual health. For fitness enthusiasts, the scans now provide insights into body composition. Additionally, Neko Health can integrate data from Apple Health, allowing medical professionals to utilize real-world information in their evaluations.
Expansion Plans
Neko Health currently operates in the U.K. and Sweden and is gearing up to launch its first location in the United States, specifically in New York. The company reports that over 100,000 individuals have undergone scans, with more than 350,000 people either on a waitlist or having scheduled appointments.
User Experiences
One notable user, Calm founder Alex Tew, shared his experience after a scan revealed a malignant mole on his back, which he subsequently had removed. Tew expressed gratitude towards Neko Health for helping him identify the issue.
Competition in Health Scanning
Neko Health is not alone in the health scanning sector. Midjourney, known for its AI image and video creation, is also developing a body scanner that will be integrated into a spa experience featuring hot tubs and saunas, set to open in San Francisco in 2027.
Investor Support
In addition to Lightspeed and O.G. Venture Partners, other investors in this funding round include Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD.